Ken Furudate

16PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyHaematological tumoursRespiratory diseasesPhylogeny and comparative analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 10, 2026
Targeting oncogenic FLT3 uncovers a ferroptosis vulnerability through selenocysteine recoding in acute myeloid leukaemia.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Sep 04, 2025
Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma.

Ken Furudate, Shuya Kasai, Tadashi Yoshizawa

|Jul 02, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.

Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno

|May 02, 2025
Prenatal Chemotherapy and Its Impact on the Genome of Fetal Hematopoiesis.

Ken Furudate, Koichi Takahashi

|Apr 04, 2025
CLL cell-derived exosomes alter the immune and hematopoietic systems.

Ivo Veletic, David M Harris, Uri Rozovski

Pageof 3

Frequent Collaborators

15 joint publications

Koichi Takahashi

7 joint publications

Hagop M Kantarjian

7 joint publications

Guillermo Garcia-Manero

6 joint publications

Farhad Ravandi